University of Buffalo

>> Sunday, January 3, 2010

Researchers at the University of Buffalo are developing an asymmetric stent to act as a monotherapy flow diverting device to exculde aneurysms from circulation. The product is pre-clinical with promising results.

0 comments:

Post a Comment

  © eReports

Back to TOP